心脏消融设备公司Imricor签署其第十个iCMR实验室站点
可视化心脏消融设备公司Imricor Medical Systems，Inc.（ ASX：IMR）宣布，已与德国柏林布赫Helios综合性医院（Helios Hospital Berlin-Buch）签署协议，成为第十个建立iCMR（介入性心脏磁共振成像）实验室的临床站点，将采用Imricor的产品在由MRI引导的环境下进行可视化的心脏消融手术。
IMR
Imricor (IMR) 的心脏消融手术设备正在推进FDA和TGA的注册
医疗设备生产商Imricor Medical Systems（ASX：IMR）发布其截至2021年3月31日的季度报告，为投资者提供MRI引导心脏消融产品推广进展、财务和运营表现。
Imricor (IMR) March Quarterly Report: Progressing Towards FDA Registration Strategy
Imricor Medical Systems (ASX: IMR) released its quarterly report for the three months ended 31 March 2021, providing investors with business updates associated with its leading MRI-guided cardiac ablation products, as well as financial and operational performance.
脱水简报- Imricor Medical Systems个股分析
Imricor Medical Systems，Inc. (ASX:IMR)是一家位于美国的医疗设备公司。该公司专注于设计，制造和销售与磁共振成像（MRI）兼容的产品，这些产品可用于治疗心律失常的心脏导管消融手术。
Imricor signed distribution agreement to facilitate sales in Australia and NZ
Imricor Medical Systems (ASX: IMR) signed a Distribution Agreement with Sydney-based medical device distributor Regional Health Care Group Pty Ltd (RGCH). Pursuant to the agreement, RHCG will be the exclusive distributor of Imicor's consumable products in Australia and New Zealand, and a non-exclusive distributor of Imicor's capital equipment.
心脏消融手术设备提供商IMR和澳新医疗设备分商RHCG签署协议
医疗设备公司Imricor Medical Systems (ASX: IMR)与悉尼医疗产品分销公司Regional Health Care Group Pty Ltd签订产品分销协议。根据协议，RHCG成为Imricor消耗品（订阅产品）的独家分销商，以及Imricor核心设备的澳洲和新西兰非独家分销商。此外，RGCH还将帮助Imricor产品在澳大利亚和新西兰获得必要的监管批准，团队预计将于2021年底获得首批批准。
心脏消融手术设备提供商IMR的最新投资者简介【中文版】
医疗器械公司Imricor (ASX: IMR) 对投资者发表一份公司最新近况介绍，61Financial再此附上中文版，放大至200%阅读更佳。
Imricor benefits as elective surgery resumed in German
Imricor Medical Systems (ASX: IMR), an ASX-listed global cardia ablation product producer, has announced today that one of its collaboration partners in Europe, the Helios Leipzig Heart Centre, has resumed elective surgery.
消融设备公司Imricor (IMR) 重启在德国的心脏手术
Imricor Medical Systems,Inc.(ASX:IMR) 宣布德国Helios Leipzig (莱比锡) 心脏中心已开始使用MRI引导的心脏消融设备进行自新冠疫情以来的首次手术。
Medical device developer Imricor (IMR) announces first successful ablation procedure since lockdown eased in Europe
Imricor Medical Systems (ASX: IMR) announced the commencement of procedures at the Netherlands-based Maastricht University Medical Centre+ (MUMC+), following the COVID-19 lockdown measures eased in Europe.